High-sensitivity C-reactive protein predicts microalbuminuria progression in essential hypertensive patients: a 3-year follow-up study

被引:0
|
作者
Yang, Yan [1 ]
Tang, Xiao-Feng [1 ]
Wang, Yan [1 ]
Xu, Jian-Zhong [1 ]
Gao, Ping-jin [1 ,2 ]
Li, Yan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hypertens, Dept Cardiovasc Med,State Key Lab Med Genom,Shangh, Shanghai, Peoples R China
[2] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Lab Vasc Biol, Shanghai, Peoples R China
关键词
high sensitivity C-reactive protein; hypertension; microalbuminuria; urinary albumin-to-creatinine ratio; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; INFLAMMATION; DISEASE; INDIVIDUALS; ASSOCIATION; ALBUMINURIA; REDUCTION; HEALTH; RISK;
D O I
10.1097/MBP.0000000000000713
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives To determine the independent effect of high-sensitivity C-reactive protein (hs-CRP) and the combined effects of hs-CRP and other traditional risk factors on microalbuminuria in hypertensive patients during the 3-year follow-up period. Methods and results Baseline hs-CRP levels and other risk factors were measured in 280 adults in 2007. In the third year of examination, 199 patients (mean age 62.5 +/- 9.5, men 59.3%) were approached for the measurement of microalbuminuria. The subjects were classified into two groups by the median of baseline hs-CRP. Compared to the patients with baseline hs-CRP below the median group (n = 99, 50%), the group with baseline hs-CRP above the median (n = 100, 50%) had higher urinary albumin-to-creatinine ratio (ACR) (P = 0.007) at the end of follow-up period. ACR at the end of follow-up period was significantly correlated with baseline diabetes (beta = 0.342; P < 0.001), baseline SBP (beta = 0.148; P = 0.02), and baseline log-transformed hs-CRP (beta = 0.169; P = 0.01), while adversely correlated with baseline estimated glomerular filtration rate (eGFR) (beta = -0.163; P = 0.02) in multivariate stepwise linear analysis. In addition, ACR change during follow-up period was significantly correlated with baseline diabetes (beta = 0.359; P < 0.001) and baseline log-transformed hs-CRP (beta = 0.190; P = 0.004) in multivariate stepwise linear analysis. The combined effects of baseline hs-CRP and conventional risk factors, such as male sex, diabetes, smoking status, hyperlipidemia, hyperuricemia, and mildly reduced eGFR had a greater risk for microalbuminuria progression. There was no difference in eGFR changes during the follow-up period between two groups. Conclusion Our findings offer a new piece of evidence on the predictive value of baseline hs-CRP for microalbuminuria progression in essential hypertensive patients, and highlight those who combined with traditional cardiovascular risk factors had a greater risk for developing microalbuminuria.
引用
收藏
页码:242 / 248
页数:7
相关论文
共 50 条
  • [41] High-sensitivity C-reactive protein is not associated with carotid intima-media progression - The carotid atherosclerosis progression study
    Lorenz, Matthias W.
    Karbstein, Peter
    Markus, Hugh S.
    Sitzer, Matthias
    STROKE, 2007, 38 (06) : 1774 - 1779
  • [42] Progression of osteoporosis in patients with COPD: A 3-year follow up study
    Graat-Verboom, Lidwien
    Smeenk, Frank W. J. M.
    van den Borne, Ben E. E. M.
    Spruit, Martijn A.
    Jansen, Frits H.
    van Enschot, Joris W. T.
    Wouters, Emiel F. M.
    RESPIRATORY MEDICINE, 2012, 106 (06) : 861 - 870
  • [43] High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention
    Oemrawsingh, Rohit M.
    Cheng, Jin M.
    Akkerhuis, K. Martijn
    Kardys, Isabella
    Degertekin, Muzaffer
    van Geuns, Robert-Jan
    Daemen, Joost
    Boersma, Eric
    Serruys, Patrick W.
    van Domburg, Ron T.
    EUROINTERVENTION, 2016, 12 (03) : 345 - 351
  • [44] TIME-AVERAGED HIGH-SENSITIVITY C-REACTIVE PROTEIN PREDICTS MORTALITY AND DROPOUT IN PERITONEAL DIALYSIS PATIENTS
    Tian, Ya-Chung
    Liu, Shou-Hsuan
    Li, Yi-Jung
    Wu, Hsin-Hsu
    Lee, Cheng-Chia
    Tu, Kun-Hua
    Lin, Chan-Yu
    Chen, Yung-Chang
    Chang, Ming-Yang
    Chen, Yu-Ming
    Hsu, Hsiang-Hao
    Yang, Chih-Wei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [45] C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study
    Ryota Iwasa
    Akihiro Yamada
    Koji Sono
    Ryuichi Furukawa
    Ken Takeuchi
    Yasuo Suzuki
    BMC Gastroenterology, 15
  • [46] C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study
    Iwasa, Ryota
    Yamada, Akihiro
    Sono, Koji
    Furukawa, Ryuichi
    Takeuchi, Ken
    Suzuki, Yasuo
    BMC GASTROENTEROLOGY, 2015, 15
  • [47] Ambulatory versus clinic blood pressure in predicting overall subclinical target organ damage progression in essential hypertensive patients: a 3-year follow-up study
    Yang, Yan
    Xu, Jian-zhong
    Wang, Yan
    Gao, Ping-jin
    BLOOD PRESSURE MONITORING, 2016, 21 (06) : 319 - 326
  • [48] Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients
    Lin, Chin-Chuen
    Chang, Chia-Ming
    Liu, Chia-Yih
    Huang, Tiao-Lai
    ASIA-PACIFIC PSYCHIATRY, 2013, 5 (02) : E58 - E63
  • [49] High-sensitivity C-Reactive Protein Response to Adalimumab in Hidradenitis Suppurativa Patients
    Zouboulis, C. D.
    Adams, D. A.
    Gu, Y.
    Goldblum, O. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S67 - S67
  • [50] The Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Chronic Kidney Diseases
    Gao, Jingli
    Wang, Aitian
    Li, Xiaolan
    Li, Junjuan
    Zhao, Hualing
    Zhang, Jianjun
    Liang, Jingtao
    Chen, Shuohua
    Wu, Shouling
    KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (01): : 84 - 94